Elder Care -

MMWR Booster for: Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022, Weekly / September 30, 2022 / 71(39);1235–1238

Posted on February 1, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Second mRNA COVID-19 Booster’s Efficacy: In nursing home residents, a second mRNA COVID-19 booster was found to be 74% effective at 60 days against severe COVID-19 outcomes

MMWR Booster for: Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19–Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease — United States, September 2022–March 2023, Weekly / January 11, 2024 / 73(1);16–23

Posted on January 19, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Bivalent mRNA COVID-19 Vaccine Effectiveness: The bivalent mRNA COVID-19 vaccine was found to be 47% effective in preventing thromboembolic events in immunocompetent persons aged ≥65 years and

MMWR Booster for: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022, Weekly / December 30, 2022 / 71(5152);1625–1630

Posted on January 2, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways 1. Effectiveness of Bivalent Booster: The study found an 84% effectiveness of the bivalent booster against COVID-19 hospitalization compared to unvaccinated individuals. 2. Relative Vaccine Effectiveness: Compared